MergerLoop
  • Home
  • All Deals
  • Newsletter
  • 20 Weeks In Report
Back to register

MergerLoop is a DDLoop project

Back to register
MN-95002

Abbott Laboratories / Exact SciencesMN-95002

View on ACCC

Processing timeline

22

days

Filed

2 Feb 2026

Abbott Laboratories - Exact Sciences - Phase 1 determination

Decision

24 Feb 2026Abbott Laboratories - Exact Sciences - Phase 1 determination
Type
Notification
Outcome
Approved
Stage
Phase 1 - initial assessment
Status
Assessment completed

Parties

Acquirer(s)

Badger Merger Sub I, Inc 10389384

Target(s) or Vendor(s)

Exact Sciences Corporation 02-0478229

Other parties

None listed

Summary

Abbott Laboratories, via Badger Merger Sub I, Inc, acquired 100% of the shares in Exact Sciences Corporation. Both US-headquartered global healthcare companies supply oncological diagnostic products in Australia. Abbott is active in diagnostics and medical devices, while Exact Sciences specialises in advanced molecular diagnostics for cancer screening.

Acquisition details

Abbott Laboratories ( Abbott ), via its wholly owned subsidiary Badger Merger Sub I, Inc, proposes to acquired 100% of the shares in Exact Sciences Corporation ( Exact Sciences ) through an Agreement and Plan of Merger. Abbott is a global healthcare company, headquartered in the US, active in the provision of diagnostics, medical devices, nutrition, and branded generic pharmaceuticals. Exact Sciences is a US headquartered company active in the provision of advanced molecular diagnostics, specialising in cancer screening, precision oncology diagnostics, and genetic testing. The parties both supply oncological diagnostic products in Australia.

Industry

Broad:Wholesale & DistributionANZSIC 3491:Professional and Scientific Goods WholesalingANZSIC 3720:Pharmaceutical and Toiletry Goods Wholesaling

Decisions and key events

24 Feb 2026Abbott Laboratories - Exact Sciences - Phase 1 determinationAttachmentPDF158.1 KB

More Wholesale & Distribution deals

  • Logic Technologies / Ace Communication DistributorsMN-95021 · Notification · Filed 21 May 2026
  • Novartis / ExcellergyMN-40019 · Notification · Approved
  • 26North Funds / Intermedia Cloud CommunicationsWA-65014 · Waiver · Approved
  • Trescal / TR CalibrationMN-90009 · Notification · Filed 14 Apr 2026
  • Lawrence & Hanson / Gordon MacdonaldMN-55013 · Notification · Approved
  • Turner Family Entities / Pedal GroupWA-10014 · Waiver · Approved